Share this
remote sampling: what it is, why it matters
by Neoteryx on Aug 1, 2018 3:51:00 AM
Microsampling refers to the collection of small, precise volumes of blood or other biological fluid (10 or 20 microliters, in most cases), as done using Mitra® devices. Volumetric Absorptive Microsampling (VAMS™), the technology on which Mitra is based, was originally created to solve for the limitations of Dried Blood Spot (DBS) cards. However, due to its ease of use, VAMS is opening the door for a range of new uses.
A particularly exciting and important area is remote sampling. Using VAMS, quantitative samples can be taken anywhere, at any time, by almost anyone, with minimal training.
Patients and participants can now take their own samples at home or elsewhere, cutting down on visits to the clinic. Thus, they will experience new ease, convenience, and freedom, and remain closer to their families, communities, and personal support networks. By taking sampling out of the clinic, and allowing patients to spend less time in the waiting room and more time in the living room, microsampling makes therapeutic drug monitoring, clinical trials, and other healthcare endeavors simpler and less disruptive for all involved.
Remote sampling enables innovations in:
It also improves access in low-resourced regions. Microsampling enables access to hard-to-reach populations in healthcare and research. Sampling can now be self-administered on mountaintops, in the rainforest, or within disadvantaged or isolated communities and populations. At Neoteryx, we're just getting started exploring the revolutionary implications and applications of remote sampling. Contact one of our trained Microsampling Specialists today to learn more and discuss how microsampling makes blood collection smarter and simpler and what remote sampling means for you.
Share this
- Venipuncture Alternative (109)
- Clinical Trials, Clinical Research (69)
- Mitra® Device (44)
- Research, Remote Research (37)
- Dried Blood Spot, DBS (32)
- Therapeutic Drug Monitoring, TDM (16)
- Decentralized Clinical Trial (DCT) (12)
- Blood Microsampling, Serology (10)
- Infectious Disease, Vaccines, COVID-19 (10)
- Microsampling (9)
- hemaPEN® Device (7)
- Toxicology, Doping, Drug/Alcohol Monitoring, PEth (6)
- Pharmaceuticals, Drug Development (5)
- Harpera® Tool (4)
- Omics, Multi-Omics (4)
- Skin Microsampling, Microbiopsy (4)
- Antibodies, MAbs (3)
- Biomonitoring, Health, Wellness (3)
- Preclinical Research, Animal Studies (2)
- April 2023 (2)
- March 2023 (2)
- February 2023 (2)
- January 2023 (3)
- December 2022 (2)
- November 2022 (3)
- October 2022 (4)
- September 2022 (3)
- August 2022 (5)
- July 2022 (2)
- June 2022 (2)
- May 2022 (4)
- April 2022 (3)
- March 2022 (3)
- February 2022 (4)
- January 2022 (5)
- December 2021 (3)
- November 2021 (5)
- October 2021 (3)
- September 2021 (3)
- August 2021 (4)
- July 2021 (4)
- June 2021 (4)
- May 2021 (4)
- April 2021 (3)
- March 2021 (5)
- February 2021 (4)
- January 2021 (4)
- December 2020 (3)
- November 2020 (5)
- October 2020 (4)
- September 2020 (3)
- August 2020 (3)
- July 2020 (6)
- June 2020 (4)
- May 2020 (4)
- April 2020 (3)
- March 2020 (6)
- February 2020 (3)
- January 2020 (4)
- December 2019 (5)
- November 2019 (6)
- October 2019 (4)
- September 2019 (5)
- August 2019 (5)
- July 2019 (4)
- June 2019 (7)
- May 2019 (6)
- April 2019 (5)
- March 2019 (6)
- February 2019 (6)
- January 2019 (8)
- December 2018 (3)
- November 2018 (4)
- October 2018 (7)
- September 2018 (8)
- August 2018 (5)
- July 2018 (8)
- June 2018 (6)
- May 2018 (5)
- April 2018 (6)
- March 2018 (5)
- February 2018 (7)
- January 2018 (4)
- December 2017 (2)
- November 2017 (3)
- October 2017 (2)
- September 2017 (4)
- August 2017 (2)
- July 2017 (4)
- June 2017 (5)
- May 2017 (6)
- April 2017 (6)
- March 2017 (5)
- February 2017 (4)
- January 2017 (1)
- July 2016 (3)
- May 2016 (1)
- April 2016 (2)
No Comments Yet
Let us know what you think